The Strike Pharma team

Per has 20+ years in clinical drug dev in leading positions. He has previously been CEO of Alligator Bioscience, Targinta, Evaxion and WntResearch. He has also held roles as Chief Medical Officer of Alligator Bioscience and Xintela.

Tina Furebring brings more than 25 years of experience in early drug development, including extensive experience in the management of preclinical therapeutic candidate projects. Throughout her career she has held senior management and leadership positions, driving both business strategy and the development of individuals and teams. As Senior Vice President at Alligator Biosciences AB, her responsibilities covered projects to generate antibody-based immuno-oncology compounds and development of the company’s technology platform.